The Zhitong Finance App learned that the Hong Kong Stock Prospectus submitted by Zhengxiang Pharmaceutical (Nanjing) Group Co., Ltd. (abbreviation: Zhengxiang Pharmaceutical) on January 30, 2026 expired on July 30, 2026. At the time of submission, CICC was the sole sponsor.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.